Pfizer and BioNTech say final analysis shows coronavirus vaccine is 95 per cent effective with no safety concerns – 9News

A final analysis of the Phase 3 trial of Pfizer's coronavirus vaccine shows it was 95 per cent effective in preventing infections, even in older adults, and caused…